AMGEN INC is 6.4x more valuable than BIOGEN INC. by market capitalization ($183.41 B vs $28.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMGN | BIIB |
|---|---|---|
| Market cap | $183.41 B | $28.68 B |
| US-listed rank | #79 | #476 |
| Revenue (latest FY) | $36.75B | $9.89B |
| Net income (latest FY) | $7.71B | $1.29B |
| Net margin | 21.0% | 13.1% |
| P/E (trailing FY) | 23.8 | 22.2 |
| SEC filings | 1,011 | 2,690 |
AMGEN INC is 6.4x more valuable than BIOGEN INC. by market capitalization ($183.41 B vs $28.68 B).
In their latest fiscal years, AMGEN INC reported $36.75B in revenue while BIOGEN INC. reported $9.89B.
Full pages: AMGEN INC and BIOGEN INC., or browse the full rankings.